R-Cin

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What R-Cin (Rifampicin) Is

R-Cin is the Cipla brand of rifampicin, a semi-synthetic rifamycin antibiotic introduced in the late 1960s and on the WHO Model List of Essential Medicines. Each opaque red-and-maroon capsule contains 300 mg, 450 mg, or 600 mg of rifampicin. Rifampicin is bactericidal against Mycobacterium tuberculosis, M. leprae, and a range of staphylococci, neisseria, and other intracellular pathogens. It is the most important sterilising drug in modern short-course TB therapy — the single agent that allowed treatment duration to drop from 18–24 months to 6 months in the 1970s.

How R-Cin Works (Mechanism)

Rifampicin binds to the β-subunit of bacterial DNA-dependent RNA polymerase, blocking the initiation of RNA transcription. Mammalian RNA polymerases are not affected because their structure differs at the rifampicin-binding pocket. The drug penetrates host cells, granulomas, abscess cavities, and cerebrospinal fluid in inflamed meninges — which is why it is so important against intracellular and partition-resistant infections. Resistance arises through point mutations in the rpoB gene encoding the polymerase β-subunit; this is why rifampicin must always be combined with at least one other active agent when treating organisms with high bacillary load (such as active TB).

Indications — What R-Cin Treats

1. Active tuberculosis (combination therapy only)

Rifampicin is the cornerstone of the WHO 6-month short-course regimen for drug-susceptible pulmonary and extrapulmonary TB:

Total minimum duration is 6 months. Longer regimens (9–12 months) are used for TB meningitis, bone/joint TB, and disseminated disease. Treatment must be supervised — directly observed therapy (DOT) is recommended in most national programmes to ensure adherence and prevent the emergence of MDR-TB.

2. Latent tuberculosis infection (LTBI)

For patients with positive TB skin test or interferon-gamma release assay but no active disease, four months of rifampicin monotherapy at 10 mg/kg/day (the 4R regimen) is one of the WHO-preferred options. The 2017 NEJM trial by Menzies et al. showed 4R was non-inferior to 9 months of isoniazid and had significantly fewer hepatotoxicity events, lower discontinuation, and better completion rates. This is the only standard situation where rifampicin is correctly used as a single agent for tuberculous infection.

3. Leprosy (multibacillary multi-drug therapy)

The WHO multidrug therapy regimen for multibacillary leprosy is monthly rifampicin 600 mg + monthly clofazimine 300 mg + daily clofazimine 50 mg + daily dapsone 100 mg, for 12 months. Rifampicin is the most rapidly bactericidal agent against M. leprae — a single 600 mg dose kills more than 99% of viable organisms.

4. Meningococcal disease prophylaxis

Close contacts of a confirmed meningococcal disease case can take rifampicin 600 mg twice daily for 2 days (adults; weight-adjusted in children) to eradicate nasopharyngeal carriage. Ciprofloxacin 500 mg single dose or ceftriaxone 250 mg IM single dose are equally acceptable alternatives, particularly when rifampicin would interact with ongoing medication.

5. Staphylococcal bone, joint, and prosthetic-device infections

Rifampicin is added to vancomycin, daptomycin, or beta-lactams for serious staphylococcal infections involving biofilm — particularly prosthetic joint infections and infective endocarditis on prosthetic valves. Rifampicin penetrates biofilm where most antibiotics cannot. It must always be combined to prevent rapid resistance.

6. Brucellosis

Rifampicin 600–900 mg/day combined with doxycycline 100 mg twice daily for 6 weeks is one of the standard WHO regimens for non-complicated brucellosis. An aminoglycoside (streptomycin or gentamicin) is added for spondylitis or endocarditis.

Dosing

Take on an empty stomach — one hour before food or two hours after. Food (especially fatty meals) reduces absorption by ~30%. Swallow capsules whole with water; do not break or open them.

Mandatory Monitoring

Additional monitoring depending on regimen: full blood count (rifampicin can cause thrombocytopenia and rare haemolytic anaemia), urea/creatinine, sputum smear/culture (for active TB — conversion at 2 months is the main efficacy marker), HIV status (TB-HIV co-infection alters the regimen).

Side Effects

Common (expected and usually harmless):

• Orange-red discolouration of urine, sweat, tears, saliva (always — confirms absorption; permanently stains soft contact lenses)
• Nausea, loss of appetite, abdominal discomfort — ease over the first 1–2 weeks
• Mild rash, particularly in the first month

Uncommon but important:

• Drug-induced hepatitis (5–10% have asymptomatic transaminase rise; ~1% develop clinical hepatitis — risk higher in older patients, alcohol users, hepatitis B/C carriers, and when combined with isoniazid + pyrazinamide)
• Flu-like syndrome — fever, chills, headache, myalgia — particularly with intermittent (twice- or thrice-weekly) dosing or after restarting
• Thrombocytopenia, haemolytic anaemia, eosinophilia (rare; immune-mediated; stop drug)
• Acute kidney injury (rare; usually with intermittent dosing)
• Hypersensitivity rash, urticaria, angioedema, anaphylaxis (rare; permanent contraindication)
• Stevens-Johnson syndrome / toxic epidermal necrolysis (very rare; permanent contraindication)

Drug Interactions

This list is not exhaustive. Always have a pharmacist or physician review every concurrent medication and supplement — including over-the-counter analgesics, herbal preparations, and complementary medicines.

Contraindications and Cautions

• Known hypersensitivity to rifampicin or any rifamycin (rifabutin, rifapentine)
• Acute liver disease, established jaundice, or chronic liver disease with significant impairment
• Concurrent saquinavir + ritonavir (severe hepatotoxicity)
• Porphyria (rifampicin can precipitate acute attacks)

Use with caution in: alcohol-use disorder, chronic hepatitis B or C, malnutrition (vitamin K deficiency → bleeding risk), older adults, history of drug-induced hepatitis. Diabetes management may become harder; insulin requirements often rise.

Pregnancy, Breastfeeding, and Children

Rifampicin is part of the standard WHO TB regimen used in pregnancy — the risks of untreated active TB to mother and foetus far outweigh the very small theoretical drug risk. Vitamin K 10 mg orally daily is added in the last 4 weeks of pregnancy to reduce neonatal bleeding risk. Compatible with breastfeeding (small amounts in milk; not enough to treat the baby and not enough to harm). Used in children at 15 mg/kg/day in active TB and at 10 mg/kg single-dose for meningococcal prophylaxis.

Storage

Store at 15–30 °C in the original blister or bottle, protected from moisture and direct sunlight. Capsules are heat-sensitive — do not transfer to a pill organiser for long periods. Keep out of reach of children. Dispose of unused or expired capsules through a pharmacy take-back scheme.

Frequently Asked Questions

Can I treat active tuberculosis with R-Cin alone?

No — never. Single-agent rifampicin for active TB causes rapid resistance and treatment failure. Active TB is treated with the 4-drug RIPE regimen (rifampicin + isoniazid + pyrazinamide + ethambutol) for 2 months, then 4 months of rifampicin + isoniazid. Single-agent rifampicin is appropriate only for latent TB infection, leprosy, meningococcal prophylaxis, certain MRSA infections, and brucellosis — all under medical supervision.

Why does rifampicin turn urine, sweat and tears orange-red?

Rifampicin and its metabolites are intensely red-orange pigments excreted in all body fluids. The colour is harmless and confirms the drug is being absorbed. It can permanently stain soft contact lenses, light-coloured clothing during sweating, and bedding. Switch to glasses or daily-disposable contacts during therapy and warn your dentist (it can stain crowns and dentures temporarily).

How should R-Cin be taken — with food or empty stomach?

Take R-Cin on an empty stomach: one hour before food or two hours after. Food — particularly high-fat meals — reduces rifampicin bioavailability by roughly 30%, which can drop blood levels below the therapeutic range. If empty-stomach dosing causes intolerable nausea, a small light snack (a couple of plain biscuits) is preferable to skipping or vomiting the dose. Take the full daily dose at one time, not split.

Will rifampicin make my contraceptive pill stop working?

Yes. Rifampicin reduces ethinyl-oestradiol and progestogen levels through hepatic enzyme induction; combined and progestogen-only pills, the patch, the vaginal ring, and progestogen implants are all unreliable during rifampicin therapy and for at least 4 weeks after stopping. Use barrier contraception (condoms) or a non-hormonal method (copper IUD) throughout. The depot injection (DMPA) and the levonorgestrel intrauterine system are considered unaffected.

Can I drink alcohol while on R-Cin?

Avoid alcohol or limit it strictly. Both rifampicin and the companion drug isoniazid are hepatotoxic, and alcohol substantially increases the risk of drug-induced hepatitis — one of the main reasons TB treatment has to be stopped. Daily alcohol use is a relative contraindication to standard regimens; tell your physician before starting.

What blood tests should I have during rifampicin therapy?

Baseline before starting: liver function tests (ALT, AST, bilirubin, alkaline phosphatase), full blood count, urea/creatinine. Repeat liver function at 2 weeks, then monthly throughout therapy — or sooner if you develop nausea, jaundice, dark urine, or right-upper-quadrant pain. Stop rifampicin (and isoniazid) and contact your physician if ALT exceeds three times the upper limit of normal with symptoms, or five times without symptoms.

Is R-Cin safe in pregnancy and breastfeeding?

Active TB in pregnancy is dangerous to both mother and foetus, and rifampicin is one of the agents considered safe in pregnancy — the WHO and most national TB programmes recommend it as part of the standard regimen. Vitamin K (10 mg orally daily) is added in the last 4 weeks of pregnancy to reduce neonatal haemorrhage risk. Rifampicin passes into breast milk in small amounts but is compatible with breastfeeding. All decisions should be made with an obstetrician and TB specialist.

What is the difference between rifampicin and rifaximin?

Both are members of the rifamycin class but they are clinically very different. Rifampicin is well absorbed systemically, used for tuberculosis, leprosy and serious bacterial infections, and is a major CYP enzyme inducer. Rifaximin is virtually non-absorbable, stays in the gut, and is used for traveller’s diarrhoea, hepatic encephalopathy, and IBS-D — it has minimal systemic side effects and minimal drug interactions. They are not interchangeable.

I am on antiretroviral therapy for HIV — can I still take rifampicin?

This needs specialist input. Rifampicin dramatically reduces blood levels of HIV protease inhibitors and several non-nucleoside reverse transcriptase inhibitors, risking ART failure and HIV resistance. Common workarounds: switch rifampicin to rifabutin (a less potent inducer), choose an ART regimen compatible with rifampicin (efavirenz-based regimens, or dolutegravir at twice-daily dosing), or sequence the treatments. Never start rifampicin without reviewing your ART regimen with the HIV physician.

How is R-Cin stored?

Store at 15–30 °C in the original packaging, protected from moisture, heat, and direct sunlight. Keep away from children — rifampicin overdose causes red discolouration of skin and severe hepatotoxicity. Dispose of expired or unused stock through a pharmacy take-back scheme rather than household waste.

Related Alternatives

Other products in Chronic Conditions that customers also view:

• Meftal-P
• Gravitor
• Kenacort
• Ciplar
• Symbicort Turbohaler

More options in Tuberculosis Treatment

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Combutol

US$18.00 – US$180.00Εύρος τιμών: από US$18.00 έως US$180.00